Authors

Marjorie G. Zauderer, MD

Latest:

Dr. Zauderer on the Importance of Optimizing Care in Mesothelioma

Marjorie G. Zauderer, MD, discusses the importance of optimizing care for patients with mesothelioma.

Sheldon M. Feldman, MD

Latest:

Dr Feldman on the Recognition of Racial Disparities in Breast Cancer

Sheldon M. Feldman, MD, discusses the recognition of racial disparities in breast cancer, as well as the mitigation of treatment-related toxicities.

Colin Vale, MD

Latest:

JAK Inhibitors Continue to Shape the Treatment Landscape of Myelofibrosis

Following the FDA approvals of the JAK inhibitors ruxolitinib, fedratinib, and pacritinib, the treatment landscape of myelofibrosis continues to grow with the use of these agents with an additional FDA review planned for momelotinib in September 2023.

Sebastian Stintzing, MD

Latest:

Dr Stintzing on the Safety Profile of Fruquintinib in mCRC

Sebastian Stintzing, MD, discusses the Q-TWiST analysis of fruquintinib plus best supportive care in metastatic colorectal cancer.

Andrew Katims, MD, MPH

Latest:

Dr Katims on the Feasibility of scRNA-seq in FGFR3+ Upper Tract Urothelial Carcinoma

Andrew Katims, MD, MPH, discusses the feasibility of using single-cell RNA-sequencing in FGFR3-mutated upper tract urothelial carcinoma

Bradford (Brad) S. Hoppe, MD, MPH

Latest:

Dr Hoppe on Outcomes of the CheckMate 744 Trial in Hodgkin Lymphoma

Bradford (Brad) S. Hoppe, MD, MPH, discusses the rationale for investigating consolidative radiotherapy in place of autologous stem cell transplant in patients with low-risk, relapsed/refractory classic Hodgkin lymphoma who have been previously treated with nivolumab plus brentuximab vedotin, as investigated in the phase 2 CheckMate 744 study, as well as key findings from this trial.

Christopher W. Ryan, MD

Latest:

Dr Ryan on the Role of Adjuvant Therapy in RCC

Christopher W. Ryan, MD, discusses the role of adjuvant therapy for patients with renal cell carcinoma.

Allison Winter, MD

Latest:

Dr Winter on Unmet Needs in Richter Transformation for Patients With CLL

Allison Winter, MD, discusses unmet needs for patients with Richter transformation from CLL.

Dana Farengo Clark, MS, LCGC, Penn Medicine

Latest:

Operational Processes and Challenges

Mark Robson, MD; John Henson, MD; Ashley Ross, MD, PhD; and Dana Farengo Clark, MS, LCGC, discuss operational processes and techniques for counseling patients about germline testing.

Jezabel Rodriguez-Blanco, PhD

Latest:

Dr Blanco on Unmet Needs for Pediatric Patients With Relapsed Brain Tumors

Jezabel Rodriguez-Blanco, PhD, discusses unmet needs for pediatric patients with relapsed brain tumors, including the need for additional treatment approaches for these patients.

Yael Simons, MD

Latest:

Dr. Simons on Racial Disparities Reported in Luminal Breast Cancer

Yael Simons, MD, discusses the racial disparities seen in African Americans patients with luminal breast cancer.

Fox Chase Cancer Center, Temple Health

Latest:

Fox Chase Cancer Center Welcomes Dr Eric Goodlev

Eric Goodlev, MD, has joined Fox Chase Cancer Center as an associate Professor in the Supportive Oncology and Palliative Care Program.

Moshe Kelsen, MBA

Latest:

Kelsen on DEI Initiatives at Columbia University in Patients With Cancer

Moshe Kelsen, MBA, discusses ongoing initiatives that aim to improve diversity, equity, and inclusion for patients with cancer receiving treatment at Columbia University.

Barbara Pistilli, MD

Latest:

Dr Pistilli on Understanding Dynamic HER2 Expression in Metastatic Breast Cancer

Barbara Pistilli, MD, discusses the importance of understanding how HER2 expression can change over time when assessing target expression in metastatic breast cancer.

Bhuvaneswari Ramaswamy, MD

Latest:

Dr. Ramaswamy on the Real-World Data Implications of Palbociclib in HR-Positive Breast Cancer

Bhuvaneswari Ramaswamy, MD, discusses the importance of real-world data when considering the efficacy of the CDK 4/6 inhibitor palbociclib in hormone receptor–positive breast cancer.

Susan Tsai, MD, MHS

Latest:

Dr. Tsai on Ongoing Research Efforts in Pancreatic Cancer

Susan Tsai, MD, MHS, discusses ongoing research efforts being made in the realm of pancreatic cancer.

Carolina Bernabe, MD

Latest:

Survey Aims to Identify COVID-19–Related Health Care Challenges in Latin America

Outbreaks of coronavirus disease 2019 are on the rise in Latin America, with more than 4 million confirmed cases. In response to this health crisis, elective medical procedures, including cancer screening and care, as well as treatment for conditions beyond the virus, have been held.

Bora Lim, MD

Latest:

Wrapping up the Pivotal Highlights From SABCS 2024 With Drs Bora Lim and Stephanie Graff

Bora Lim, MD, of The University of Texas MD Anderson Cancer, and Stephanie Graff, MD, of Brown University Health, sit down with Chandler Park, MD, FACP, to discuss the latest abstracts in breast cancer presented during the 2024 San Antonio Breast Cancer Symposium.

Loretta J. Nastoupil, MD

Latest:

Dr Nastoupil on the Background of the TRANSCEND FL Trial in Follicular Lymphoma

Loretta J. Nastoupil, MD, discusses the rationale for launching the phase 2 TRANSCEND FL trial evaluating lisocabtagene maraleucel in patients with relapsed/refractory follicular lymphoma, highlighting the background for investigating this treatment approach.

David H. Harpole Jr, MD

Latest:

Test for Summarization

Kathleen N. Moore, MD, MS, discusses the challenges with utilizing immune-targeted therapy for ovarian cancer, expands on the impact of the tumor microenvironment on the effectiveness of immune checkpoint inhibitors, and details ongoing research with different treatment approaches in ovarian cancer.